Your Gut Is Running Your Hormones. And Nobody Told You.

Let me tell you something that should be in every OB/GYN textbook — but isn’t.

The Metabolic Fix | hweissmd on Substack

Your gut microbiome is not just a digestive organ. It is a hormonal control center. And for women with PCOS, endometriosis, or uterine fibroids, that distinction matters more than almost anything else your doctor has told you.

I’ve spent 25 years in clinical OB/GYN, and the emerging science on the gut-hormone axis has fundamentally changed how I think about these conditions. What I’m sharing today is not fringe. It’s published in The Lancet, Frontiers in Microbiology, Physiological Reviews, and the American Journal of Obstetrics. It’s peer-reviewed, reproducible, and urgently underutilized in clinical practice.

Let’s go deep.

Part 1: The Estrobolome — Your Gut’s Secret Hormone Department

Here’s a concept most gynecologists don’t talk about: the estrobolome.

The estrobolome is the collection of gut bacterial genes responsible for metabolizing estrogen. These bacteria produce an enzyme called beta-glucuronidase, which deconjugates estrogen in the gut, allowing it to be reabsorbed into circulation rather than excreted. Think of it as a recirculation pump for estrogen.

When your gut flora is balanced, this process is tightly regulated. Estrogen is metabolized, cleared, and eliminated appropriately. When your gut is dysbiotic — overgrown with the wrong bacteria, or depleted of keystone species — beta-glucuronidase activity increases, estrogen recirculates excessively, and you end up with what clinicians call estrogen dominance.

Key finding: Gut bacteria in the families Lachnospiraceae and Actinomycetaceae have been associated with higher fibroid burden — likely through dysregulated estrogen recirculation. (Frontiers in Cellular and Infection Microbiology, 2023)

This mechanism links gut dysbiosis directly to:

• Uterine fibroid growth (estrogen-driven)

• Endometriosis progression (estrogen-dependent tissue proliferation)

• Estrogen excess symptoms: heavy periods, breast tenderness, mood disruption

The gut is not separate from your reproductive organs. It is managing them — silently, continuously, and powerfully.

Part 2: PCOS and the Microbial Fingerprint

PCOS affects 10–13% of reproductive-age women globally. Up to 70% don’t know they have it. It is the leading cause of ovulatory infertility. And the medical system is still treating it almost entirely with birth control pills and metformin.

But here is what the research increasingly shows: PCOS has a gut microbiome signature.

A 2024 meta-analysis published in eClinicalMedicine (The Lancet) found that women with PCOS have measurably less diverse gut microbiomes than controls — with specific depletions in Prevotella and enrichment in pro-inflammatory Bifidobacterium strains and Enterobacteriaceae. These are not random findings. They have mechanistic consequences:

• Reduced microbial diversity → impaired short-chain fatty acid (SCFA) production → worsened insulin resistance

• Loss of Prevotella → disrupted carbohydrate fermentation and gut barrier integrity

• Excess Enterobacteriaceae → elevated lipopolysaccharide (LPS) → systemic low-grade inflammation

Then there’s the neuroendocrine angle.

Some gut bacteria produce GABA (gamma-aminobutyric acid), a neurotransmitter that influences GnRH pulsatility and, downstream, LH secretion. In PCOS, elevated LH relative to FSH is a defining feature. The gut may be a driver of that hormonal disruption — not just a bystander. (Tremellen & Pearce, Frontiers in Microbiology, 2012)

This is the gut-brain-ovary axis. It is real. It is measurable. And it is a therapeutic target.

Part 3: Endometriosis — When Bacteria Meet the Pelvis

Endometriosis has long been framed as a hormone problem. Estrogen drives ectopic tissue growth, so we suppress estrogen — with Lupron, with progesterone, with surgery. And yet millions of women continue to suffer even after aggressive hormonal treatment.

Emerging research suggests we’ve been missing a co-driver: microbial contamination.

The “bacterial contamination hypothesis,” supported by research published in Reproductive Medicine and Biology, proposes that bacteria — and their endotoxins — reach the peritoneal cavity via retrograde menstruation or lymphatic spread, triggering a local inflammatory response that creates a permissive environment for endometriotic tissue implantation and growth.

Women with endometriosis have been found to have:

• Higher bacterial load in uterine tissue and menstrual blood compared to controls

• Elevated peritoneal LPS — a bacterial endotoxin — associated with macrophage activation

• Altered vaginal microbiomes with reduced protective Lactobacillus species

Endometriosis is not just a hormonal disease. It is a neuro-immune-microbial disease. Recognizing that changes the entire therapeutic conversation.

Part 4: What You Can Do Right Now

The clinical application of this science is still evolving, but there are actionable, evidence-supported interventions:

1. Support the estrobolome with diet

High-fiber diets increase fecal estrogen excretion and reduce estrogen recirculation. Cruciferous vegetables (broccoli, cauliflower, Brussels sprouts) support hepatic estrogen detoxification via DIM (diindolylmethane). Fermented foods — kimchi, kefir, sauerkraut — support microbial diversity.

2. Target insulin resistance directly

In PCOS, insulin resistance drives androgen overproduction and gut dysbiosis simultaneously. The combination of myo-inositol (2,000 mg) and D-chiro-inositol (50 mg) — at the validated 40:1 ratio — remains one of the most evidence-supported interventions for restoring ovulation and improving insulin sensitivity. (Unfer et al., 2012; Nestler et al., 1999)

3. Consider targeted probiotic support

Lactobacillus rhamnosus and L. acidophilus have demonstrated gut barrier restoration and anti-inflammatory effects in PCOS-relevant models. Bifidobacterium longum has been associated with improved estrogen clearance via estrobolome modulation.

4. Address Vitamin D deficiency

Vitamin D deficiency is nearly ubiquitous in women with PCOS and endometriosis and has documented roles in immune modulation, insulin sensitivity, and ovarian function. Testing and repleting to 40–60 ng/mL is a low-cost, high-yield intervention.

The Bottom Line

The gut microbiome is not a wellness buzzword. It is a regulatory system for hormones, immunity, and metabolic function — and it sits at the intersection of every major gynecologic condition that currently lacks a cure.

Understanding this connection is not optional for women with PCOS, endometriosis, or fibroids. It is foundational.

The medical system is catching up slowly. The research is there. The question is whether your care team is paying attention to it.

At ProvationLife, this is exactly what we’re building toward — tools, protocols, and formulations that translate this science into real clinical benefit for real women.

If this opened your eyes, share it. And if you want to go deeper, the next post in this series covers targeted supplementation for the gut-hormone axis — with full dosing rationale and source citations.

— Dr. Herm Weiss, MD, MBA, FACOG | Dr. Herman Weiss

Medical Disclaimer

The information provided in this blog post and newsletter is for educational and informational purposes only. It does not constitute medical advice or professional services and should not be used to diagnose or treat any health problem or disease. Always seek the advice of your physician or other qualified health‑care provider regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read here.

Use of this content does not create a doctor–patient relationship. Individual responses to treatments and lifestyle changes can vary, and only your healthcare provider can evaluate your specific circumstances. If you are experiencing a medical emergency, call your local emergency services immediately.